Oncoinv

Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnostics is vital. As more and curative treatments options are available the earlier cancer is diagnosed and the negative impact on quality of life is reduced. We are in need of a multi cancer test and OncoInv offers you one. OncoSeek® is a low cost detection and diagnostics test for cancer OncoSeek® uses a combination of 7 specific plasma tumor markers, a new multivariate algorithm, big data and AI. It performs early screening for the most common cancers, calculates the cancer risk score (CRS), and traces the cancer tissue of origin (TOO). It’s scientifically validated and CE-certified. OncoSeek can be easily implemented as it uses existing medical infrastructure. OncoSeek® can be used anywhere in the world by medical organisations who provide health services to the public. Laboratory services are included when needed. About Oncolnv OncoInv is an initiative of Inspire2Live. It’s our mission to ensure that people worldwide have early access to treatment of cancer by means of early detection. OncoInv works together with SeekIn, the developer of OncoSeek®, to reach that mission.